Warning all Foreign Companies in China: Don’t be the next GlaxoSmithKline

Published date20 May 2014
Law FirmFaegre Drinker Biddle & Reath LLP
AuthorMatthew Levy
Subject MatterAnti-Corruption,Bribery,China,Compliance,Foreign Corporations,GlaxoSmithKline,Pharmaceutical Industry

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT